Talk:Regulatory status by jurisdiction
Discussion page·2 threads·no archives
This is the discussion page for the article Regulatory status by jurisdiction. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.
Structure of the jurisdiction material
The article is trying to be a framework and a survey at once. I would rather it were purely a framework, with any jurisdiction-specific material moved to dedicated articles. Tagging for cleanup. — ImportPolicyIggy (talk) 09:40, 2 April 2026 (UTC)
Agreed. A wiki that attempts to state the law of many jurisdictions will be wrong somewhere and out of date everywhere. The framework is defensible and durable. — ScopeSeverin (talk) 13:15, 2 April 2026 (UTC)
Leaving the tag until the sub-national material is either removed or given its own home. — StateBoardStace (talk) 09:05, 3 April 2026 (UTC)
Presentation testResolved
The presentation test is the most practically important mechanism here — claims can bring a product within medicines law regardless of a research-use label. — LabelLibby (talk) 10:15, 5 June 2026 (UTC)
Stated as a mechanism rather than as a warning to anyone in particular. ✓ Done — GreyMarketGreer (talk) 13:50, 5 June 2026 (UTC)